公司資料
Passage Bio 股價、新聞與催化劑
- 股票代碼:
- PASG
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
5.04 USD (+3.70%)
收盤價
最後更新: 2026年9月17日
18.9M USD
市值
股價為何變動
截至 2026年9月17日，PASG 上漲 3.70%，收於 $5.04。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Passage Bio is a gene-therapy company focused on rare and neurological diseases. Its business has centered on the challenge of translating genetic medicine into the central nervous system.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Passage sits in advanced biotechnology.
商業模式特徵
The company depends on clinical data, delivery science, and the ability to create value in rare genetic disease.
生技產業定位
Passage is a high-catalyst gene-therapy name whose valuation is tied to early clinical outcomes.
未來催化劑
- Passage Bio’s catalysts are its rare-CNS gene-therapy programs and any strategic update that clarifies which assets still matter. The company needs stronger clinical clarity.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。